GLE vs RVPH Comparison

Global Engine Group Holding Ltd offers integrated solutions by using ICT solutions to drive business outcomes and innovation. Its service offerings comprise services to telecom operators, including the one-stop shop purchase from telecom license application service to turnkey network setup as well as service outsourcing; business planning, development, technical and operations consulting programs structured to target the cloud computing and data center providers; system design, planning, development and operation services to technology companies; cloud platform deployment, IT system design and configuration services, maintenance services, data center colocation service and cloud service.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.